- Program Overview
The Centre for Aging + Brain Health Innovation (CABHI) is excited to launch its third round of the I2P2 program. This program is an opportunity for companies around the world to accelerate their disruptive senior care innovations by testing them in a real world environment. I2P2 gives companies an opportunity to obtain the evidence and user validation required for widespread procurement and adoption of their products. Successful applicants will be partnered with one or more seniors care organizations (trial sites) and receive up to $500,000 (CAD) in matching fund support. Trial sites are drawn from a registry of leading healthcare organizations from across Canada and the US, including long-term care, community care, hospitals, memory clinics, day programs and other healthcare service organizations from both public and private sectors. CABHI will provide project management, applied research and other resources to maximize project benefit for selected companies. Projects must last between 12 – 15 months and commence by August 2018. Interested companies must submit their online application no later than 5 pm (EST) on March 12, 2018.
|Program Announcement||February 15, 2018|
|Applicants submit online application||March 12, 2018 by 5 pm EST|
|CABHI invites shortlisted applicants for Pitch Day||March 21, 2018|
|Pitch Day||April 20, 2018|
|CABHI notifies selected applicants||April 27, 2018|
|Sign agreements||July 31, 2018|
|Start project||August, 2018|
CABHI supports innovations that address challenges associated with the aging brain, including dementia and other neurodegenerative diseases. In 2018, CABHI is focusing on the following priority areas:
- Aging in place: solutions that enable older adults with dementia to maximize their choice, independence and quality of life to enable aging in the most appropriate setting
- Caregiver support: solutions that support caregivers (formal and informal) providing care to older adults with dementia
- Care coordination and navigation: solutions that help older adults, caregivers and healthcare providers coordinate care and transitions for older adults with dementia
- Cognitive health: solutions that focus on promoting brain health, the prevention of brain disease, early diagnostics, and slowing the progression of cognitive impairment for older adults
- Vendor Application: Companies apply with solutions they wish to pilot with one or more seniors care organizations. Applications are reviewed and shortlisted by CABHI’s review panel. Shortlisted companies are invited to a ‘Pitch Day’ competition.
- Pitch Day: Companies present to a panel of industry, scientific and clinical experts. Winners proceed to the trial partner brokering phase, with a commitment from CABHI to provide matching project funds (conditional on successfully being brokered with a trial partner and final approval of the project by CABHI).
- Trial partner brokering: CABHI works with winners to select up to two trial sites to evaluate their solution and finalize the details of their project. CABHI will leverage its network of trial site partners, applied research experts, and clinical adoption specialists to maximize the impact of projects on uptake of the innovation. (Companies may also identify eligible trial partner organizations to work with).
- Applicant must be a for-profit company
- Applicant must have good financial standing and have sufficient resources to complete an operational trial for 12-15 months
- Solution must clearly address at least one of the CABHI innovation themes
- Solution must have all licensing and certifications necessary for trial prior to project start
- Solution must be ready for use in an operational setting in its current form
- Applicant must intend to make the solution commercially available once the trial is completed.
- Solution must be innovative in that it:
- displaces existing solutions
- significantly enhances the effectiveness of existing solutions or
- involves revolutionary technology that substantially alters care delivery
- Project must focus on generating evidence required for procurement and adoption
- Initiative cannot involve basic research, primarily academic goals, capital investment in a portfolio of intellectual property, pharmaceutical clinical trials or incubators for startups
All applications will be evaluated based on the following criteria:
- Quality of Solution: How effectively does the solution address the identified problem? What is the quality of the existing evidence? How innovative, unique or ‘breakthrough’ is the solution proposed?
- Strategic Impact: How well does the project align with CABHI’s priority themes for 2018? How clearly defined and significant is the problem being solved?
- Market opportunity/commercial merit: What is the demonstrated size and value of the potential market for the solution? What is the quality of the company’s business and service model? How ready is the solution to be scaled across Canada and beyond?
- Project goals: How will this project directly contribute to the company’s strategic approach and commercialization plan? What outcomes and metrics is the project seeking to produce? How will you involve target users in the testing of this solution? How will you share the evidence to the appropriate audience(s) once you have tested the solution in a real-world environment?
- Company and team experience: Demonstrated track record of relevant successes and qualifications of key members of the project team
Funding from CABHI:
Each selected applicant will be able to lever a maximum of $500,000 (CAD) from CABHI to support up to 50% of the eligible project costs. The project will be undertaken at the identified trial-partner site(s). Funds will flow directly to the trial partner site(s), and be spent on costs directly relating to the pilot evaluation. Funds may not be used to directly compensate the company.
Funding from the selected company (applicant):
Companies must match CABHI’s contribution through a blend of cash and/or in-kind project support. Companies must pay an administrative fee to CABHI equal to 10% of the total project cost.
For example, if the total eligible project cost to execute the project is $400,000 (CAD), then cash and in-kind contribution by the company would equal $200,000 (CAD). CABHI would provide $200,000 (CAD) in cash directly to the trial site(s).
In the above example, the selected company must pay CABHI a service fee of $40,000 (CAD).
Flow of Funds from CABHI
CABHI will release an initial payment of 30% of the funds at the start of the project to the seniors’ care organization(s) where the validation testing will be conducted. Subsequent payments (two installments of 30%) will be released upon receipt and approval of interim reports from the trial site(s). A holdback of 10% will be released upon project completion and receipt of final progress and financial reports, outcomes and attestation from the seniors care organization conducting the validation testing regarding the use of funds.
The benefits of participating in the Industry Innovation Partnership Program include:
- An opportunity to connect with leading care organizations from across Canada and the US, accessing a wide array of end user populations in a variety of settings (from institutional care to the community)
- An opportunity to generate objective scientific evidence and user validation of the effectiveness of the company’s product or service, helping to differentiate the product or service in the marketplace.
- Access to a variety of acceleration services, including support for research design, ethics and implementation, market strategy, health system adoption, and access to CABHI’s senior advisory panel.
- An opportunity to have your innovation profiled and disseminated via CABHI marketing and communication activities
- An opportunity to promote adoption of the product or service through a North American network of leading seniors’ care organizations following a successful trial.
Additional rules and obligations
- CABHI will not obtain any ownership rights to the intellectual property associated with the product or service, but will retain the right to disseminate the results of the testing.
- CABHI reserves the right to select proposals that represent a distribution of projects across the 2018 innovation themes and geographic spread across trial partners’ sites located across Canada.
- CABHI may terminate negotiations or invite an alternate applicant to engage in negotiations if a contract is not signed in a reasonable amount of time (determined exclusively by CABHI).
- CABHI reserves the right to decline any application and to modify or annul this Call for Innovations at any time, without incurring any liability.
- Each project must include at least one Canadian organization, either the company or at least one of the trial partner sites.
Funding for this program is provided by the Government of Ontario through the Ministry of Research, Innovation, and Science, as well asthe Government of Canada through the Public Health Agency of Canada and the Baycrest Foundation.